Dossier assessment
Rurioctocog alfa pegol (haemophilia A) - Benefit assessment according to §35a Social Code Book V
Report documents
-
Extract of dossier assessment
Rurioctocog alfa pegol (haemophilia A) - Benefit assessment according to §35a Social Code Book V
-
Dossier assessment
Rurioctocog alfa pegol (haemophilia A) - Benefit assessment according to §35a Social Code Book V
Dossier assessment
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency) aged 12 years or older
No study data; added benefit not proven in comparison with the appropriate comparator therapy
Project details
- Project no.
- A18-32
- Commission
- Commission awarded on 16.05.2018 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Haematology
- Note
-
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.